Basically the business model of big pharmaceutical companies wasn’t to do their own research and development, but was to find smaller firms that had come up with new, innovative drugs, buy them, get every dollar they could out of the patents they had, and then use the profits to enrich shareholders and executives.
Reporter, public records requester, researcher Julia Rock joins us to discuss her article at The Lever, "How Big Pharma Actually Spends Its Massive Profits: New research shows that pharmaceutical companies have spent more on enriching shareholders than drug research and development over the past decade."